tiprankstipranks
Vita Life Sciences Limited (AU:VLS)
:VLS
Australian Market
Holding AU:VLS?
Track your performance easily

Vita Life Sciences Limited (VLS) Share Price & Analysis

10 Followers

VLS Stock Chart & Stats


Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

2.56%97.44%
― Other Institutional Investors
97.44% Public Companies and
Individual Investors

VLS FAQ

What was Vita Life Sciences Limited’s price range in the past 12 months?
Vita Life Sciences Limited lowest share price was AU$1.76 and its highest was AU$2.50 in the past 12 months.
    What is Vita Life Sciences Limited’s market cap?
    Vita Life Sciences Limited’s market cap is AU$109.42M.
      When is Vita Life Sciences Limited’s upcoming earnings report date?
      Vita Life Sciences Limited’s upcoming earnings report date is Feb 20, 2025 which is in 29 days.
        How were Vita Life Sciences Limited’s earnings last quarter?
        Vita Life Sciences Limited released its earnings results on Aug 26, 2024. The company reported AU$0.078 earnings per share for the quarter, beating the consensus estimate of N/A by AU$0.078.
          Is Vita Life Sciences Limited overvalued?
          According to Wall Street analysts Vita Life Sciences Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Vita Life Sciences Limited pay dividends?
            Vita Life Sciences Limited pays a Annually dividend of AU$0.094 which represents an annual dividend yield of 4.83%. See more information on Vita Life Sciences Limited dividends here
              What is Vita Life Sciences Limited’s EPS estimate?
              Vita Life Sciences Limited’s EPS estimate for its next earnings report is not yet available.
              How many shares outstanding does Vita Life Sciences Limited have?
              Vita Life Sciences Limited has 55,685,580 shares outstanding.
                What happened to Vita Life Sciences Limited’s price movement after its last earnings report?
                Vita Life Sciences Limited reported an EPS of AU$0.078 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -3.604%.
                  Which hedge fund is a major shareholder of Vita Life Sciences Limited?
                  Currently, no hedge funds are holding shares in AU:VLS
                  ---

                  Vita Life Sciences Limited Stock Smart Score

                  10
                  Unlock Smart Score
                  1
                  2
                  3
                  4
                  5
                  6
                  7
                  8
                  9
                  10

                  Technicals

                  SMA
                  Negative
                  20 days / 200 days
                  Momentum
                  18.01%
                  12-Months-Change

                  Fundamentals

                  Return on Equity
                  21.36%
                  Trailing 12-Months
                  Asset Growth
                  25.31%
                  Trailing 12-Months

                  Company Description

                  Vita Life Sciences Limited

                  Vita Life Sciences Ltd is an Australian based pharmaceutical and healthcare company involved in formulating, packaging, sales, and distribution of vitamins and supplements. The company produces a wide range of premium supplements, vitamins, minerals, herbs and superfoods catered to all age categories and health conditions. The company markets its products through pharmacies and health food stores under the VitaHealth, Herbs of Gold brands..
                  ---
                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Compumedics Limited
                  PainChek Ltd
                  Alcidion Group Limited
                  Emyria Ltd
                  Popular Stocks
                  ---
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis